Clinical Trial Update: Sorafenib in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of sorafenib in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED